FDA Adverse Event Injury Summary report: N

XENIUM DIALYZER

MDR report key: 1160482 · Received September 12, 2008

Report

Report Number
1423500-2008-00796
Event Type
Injury
Date Received
September 12, 2008
Date of Event
August 18, 2008
Report Date
August 25, 2008
Manufacturer
NIPRO CORPORATION
Product Code
KDI
PMA / PMN Number
K062079
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

A REQUEST FOR THE RETURN OF THE SAMPLE HAS BEEN MADE. SHOULD A SAMPLE BE RECEIVED FOR EVALUATION, A FOLLOW-UP REPORT WILL BE FILED UPON COMPLETION OF AN EVALUATION OR IF ANY ADDITIONAL INFORMATION BECOMES AVAILABLE.

Description of Event or Problem · 1

INTERNATIONAL FACILITY FROM BRAZIL REPORTED: IN 2008, AFTER THE FIRST SESSION OF HEMODIALYSIS, A PATIENT WITH CHRONIC KIDNEY DISEASE EXPERIENCED THORACIC PAIN AT HOME AFTER THERAPY USING A XENIUM DIALYZER. THE PATIENT WAS DIAGNOSED WITH PLEURAL EFFUSION THROUGH X-RAY OF THE CHEST. THE PATIENT WAS ADMITTED IN THE HOSPITAL ON THE NEXT DAY, AND CURRENTLY REMAINS HOSPITALIZED. THIS PATIENT IS PATIENT NUMBER 1 OF DIALYSIS CENTER 1 ON A STUDY TO DETERMINE THE EFFECT OF MANUAL REPROCESSING WITH PERACETIC ACID AFFECTING THE PERFORMANCE OF THE XENIUM LF 190 DIALYZER. THE INVESTIGATOR DOES NOT CONSIDER THAT THE EVENT LINKS WITH THE PRODUCT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XENIUM DIALYZER 78KDI KDI NIPRO CORPORATION 08A10SX

Patients

Seq Age Sex Outcome Treatment
1 80 YR Hospitalization| R ASPIRIN 200 MG| ATENOLOL 50 MG| OMEPRAZOLE 20 MG| PROPALTYNITRATE 20 MG| SEVELAMER CHLORIDE 800 MG| INSULIN NPH 16 U| ATORVASTATIN 20 MG| ANLODIPINE 5 MG| EPOGEN 8000 IU